4//SEC Filing
Mylet Johanna 4
Accession 0001209191-23-014908
CIK 0001661460other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 6:28 PM ET
Size
9.5 KB
Accession
0001209191-23-014908
Insider Transaction Report
Form 4
Mylet Johanna
Chief Financial Officer
Transactions
- Award
Common Stock
2023-03-01+92,772→ 181,954 total - Tax Payment
Common Stock
2023-03-01$5.35/sh−4,323$23,128→ 177,631 total - Award
Employee Stock Option (Right to Buy)
2023-03-01+125,283→ 125,283 totalExercise: $5.35Exp: 2033-02-28→ Common Stock (125,283 underlying)
Footnotes (4)
- [F1]Represents shares issuable upon the vesting of restricted stock units granted pursuant to the Issuer's Equity Incentive Plan. The RSUs are scheduled to vest in four equal annual installments.
- [F2]Includes 3,000 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on March 18, 2022, and 1,951 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on September 20, 2022.
- [F3]Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on March 1, 2022.
- [F4]12.5% of the shares subject to the stock option will vest and become exercisable on the six-month anniversary of the grant date listed in column 3 above, and the remaining shares will vest in 42 equal monthly installments thereafter.
Documents
Issuer
Poseida Therapeutics, Inc.
CIK 0001661460
Entity typeother
Related Parties
1- filerCIK 0001765988
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 6:28 PM ET
- Size
- 9.5 KB